Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2013

Open Access 01-12-2013 | Research

Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?

Authors: Yaakov Bentov, Eliezer Burstein, Courtney Firestone, Ross Firestone, Navid Esfandiari, Robert F Casper

Published in: Reproductive Biology and Endocrinology | Issue 1/2013

Login to get access

Abstract

Background

When stimulating a patient with poor ovarian response for IVF, the maximal dose of gonadotropins injected is often determined by arbitrary standards rather than a measured response. The purpose of this study was to determine if serum FSH concentration during an IVF stimulation cycle reflects follicular utilization of FSH and whether serum FSH values may inform dose adjustments of exogenous FSH.

Methods

In this retrospective cross sectional study we studied 155 consecutive IVF cycles stimulated only with recombinant human FSH. We only included long GnRH agonist protocols in which endogenous FSH levels were suppressed. We correlated the serum concentration of cycle day (CD) 7 FSH with the number of oocytes retrieved, cleaving embryos and pregnancy rate.

Results

We found that a CD7 FSH concentration above 22 IU/L was associated with poor response regardless of the daily dose of FSH injected and a lower pregnancy rate.

Conclusions

We concluded that CD7 FSH concentration during stimulation could be used to guide FSH dosing in poor responders. If the CD7 FSH concentration is above 22 IU/L increasing the dose of FSH in an attempt to recruit more growing follicles is unlikely to be successful.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bodri D, Sunkara SK, Coomarasamy A: Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertil Steril. 2011, 95: 164-169. 10.1016/j.fertnstert.2010.06.068.CrossRefPubMed Bodri D, Sunkara SK, Coomarasamy A: Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertil Steril. 2011, 95: 164-169. 10.1016/j.fertnstert.2010.06.068.CrossRefPubMed
2.
go back to reference Feigenberg T, Simon A, Ben-Meir A, Gielchinsky Y, Laufer N: Role of androgens in the treatment of patients with low ovarian response. Reprod Biomed Online. 2009, 19: 888-898. 10.1016/j.rbmo.2009.09.012.CrossRefPubMed Feigenberg T, Simon A, Ben-Meir A, Gielchinsky Y, Laufer N: Role of androgens in the treatment of patients with low ovarian response. Reprod Biomed Online. 2009, 19: 888-898. 10.1016/j.rbmo.2009.09.012.CrossRefPubMed
4.
go back to reference Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H: Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril. 1993, 59: 738-742.PubMed Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H: Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril. 1993, 59: 738-742.PubMed
5.
go back to reference Mannaerts BM, Rombout F, Out HJ, Coelingh Bennink H: Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update. 1996, 2: 153-161. 10.1093/humupd/2.2.153.CrossRefPubMed Mannaerts BM, Rombout F, Out HJ, Coelingh Bennink H: Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update. 1996, 2: 153-161. 10.1093/humupd/2.2.153.CrossRefPubMed
6.
go back to reference Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L: ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011, 26: 1616-1624. 10.1093/humrep/der092.CrossRefPubMed Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L: ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011, 26: 1616-1624. 10.1093/humrep/der092.CrossRefPubMed
7.
go back to reference Mannaerts B, Fauser B, Lahlou N, Harlin J, Shoham Z, Bennink HC, Bouchard P: Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril. 1996, 65: 406-410.PubMed Mannaerts B, Fauser B, Lahlou N, Harlin J, Shoham Z, Bennink HC, Bouchard P: Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril. 1996, 65: 406-410.PubMed
8.
go back to reference Selman H, Pacchiarotti A, El-Danasouri I: Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil Steril. 2011, 94: 1782-1786.CrossRef Selman H, Pacchiarotti A, El-Danasouri I: Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil Steril. 2011, 94: 1782-1786.CrossRef
9.
go back to reference Fletcher PW, Reichert LE: Cellular processing of follicle-stimulating hormone by Sertoli cells in serum-free culture. Mol Cell Endocrinol. 1984, 34: 39-49. 10.1016/0303-7207(84)90157-6.CrossRefPubMed Fletcher PW, Reichert LE: Cellular processing of follicle-stimulating hormone by Sertoli cells in serum-free culture. Mol Cell Endocrinol. 1984, 34: 39-49. 10.1016/0303-7207(84)90157-6.CrossRefPubMed
10.
go back to reference Katz P, Showstack J, Smith JF, Nachtigall RD, Millstein SG, Wing H, Eisenberg ML, Pasch LA, Croughan MS, Adler N: Costs of infertility treatment: results from an 18-month prospective cohort study. Fertil Steril. 2011, 95: 915-921. 10.1016/j.fertnstert.2010.11.026.PubMedCentralCrossRefPubMed Katz P, Showstack J, Smith JF, Nachtigall RD, Millstein SG, Wing H, Eisenberg ML, Pasch LA, Croughan MS, Adler N: Costs of infertility treatment: results from an 18-month prospective cohort study. Fertil Steril. 2011, 95: 915-921. 10.1016/j.fertnstert.2010.11.026.PubMedCentralCrossRefPubMed
11.
go back to reference Gonzalez-Comadran M, Duran M, Sola I, Fabregues F, Carreras R, Checa MA: Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis. Reprod Biomed Online. 2012, 25: 450-459. 10.1016/j.rbmo.2012.07.011.CrossRefPubMed Gonzalez-Comadran M, Duran M, Sola I, Fabregues F, Carreras R, Checa MA: Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis. Reprod Biomed Online. 2012, 25: 450-459. 10.1016/j.rbmo.2012.07.011.CrossRefPubMed
12.
go back to reference Gomaa H, Casper RF, Esfandiari N, Chang P, Bentov Y: Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF. Reprod Biol Endocrinol. 2012, 10: 55-10.1186/1477-7827-10-55.PubMedCentralCrossRefPubMed Gomaa H, Casper RF, Esfandiari N, Chang P, Bentov Y: Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF. Reprod Biol Endocrinol. 2012, 10: 55-10.1186/1477-7827-10-55.PubMedCentralCrossRefPubMed
Metadata
Title
Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?
Authors
Yaakov Bentov
Eliezer Burstein
Courtney Firestone
Ross Firestone
Navid Esfandiari
Robert F Casper
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2013
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-11-12

Other articles of this Issue 1/2013

Reproductive Biology and Endocrinology 1/2013 Go to the issue